anesthesia glp-1 guidance news Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement GLP-1 medications safe to continue
Description
Do not change your dose unless your healthcare provider has told you to change your dose
Whether you are using Compounded Semaglutide or Compounded Tirzepatide , our programs are designed to monitor your progress and ensure your body remains nourished and healthy
It is therefore important to keep in mind (1) the risk of over-basalization and (2) guideline recommendations that basal insulin therapy should be escalated to combination injectables when the basal insulin dose exceeds 0.5 Units/kg BW/day
A provider-guided approach ensures safety and helps distinguish medication-related headaches from other causes
GLP-1 receptor agonists (glucagon-like peptide-1) are a class of medications that mimic a natural hormone in your body
